Yes, the little green men and the Elvis replicants are plotting to take it down in September, and no sooner...not even a day. On the other side, there are the tall greys and the sasquatches, which are accumulating.
They are too incompetent to know what the dude in the cubicle to the left did last week. It is an awful website for everything except their ex-dividend watch
That is very nice of you. My mom is in FL, but she will be just fine. I work with a woman who is taking her son down to LEGOLAND on Monday...she is a little freaked out. But Legos are waterproof!
the insurers are playing hard ball in the negotiating, because they know saving a buck or two per month per scrip will really add up after this drug proliferates. That savings will end up being millions every month, so they are taking it seriously. But that will soon get resolved. This is not unusual.
Yes, Klarman would be a buyer in that situation, which is clearly one of short-term inefficiency and manipulation, provided it was not a value trap (and this is not even close to a value trap). You keep buying and you wait 3-5 years, and than you laugh. That is how Baupost averaged over 20% returns for the last three decades.
Roxadustat is an drug that provides iron.
Auryxia is a phosphate binder that happens to also increase iron.
If you took Rox, you would still need to take a phosphate binder, unless you never needed one. About 80% of stage 5 CKD patients require both. If you need to take both a phosphate binder and iron, Auryxia may obviate or reduce that need for iron. No other phosphate binder does that, and no iron option will lessen or eliminate the need for a phosphate binder (at least until Auryxia becomes approved as an iron drug too).
They will get there. If this stock tanks because they are not over 300, buy more shares. The investment will pay off, because once this drug gains traction with the large players (davita, fres and the insurers), the move in scrips will be significant. This is not a question of if, but when, and if you have the money and do not need it beck this year, just buy more on any weakness. I will.
Are you asking, in a word, why?
Because it is worth more than the existing market value, and because it was just determined that some of the dirty tactics being used to hurt the company are not legal, and so the impediments shall not continue.
Pharmacovigilance Risk Assessment Committee (PRAC)
Yes, you can search for it and other things on the interweb.
there is nothing wrong with 100k shares in the 6s. That should work out better than most investments, and in just a year or two should be all the money anyone will need.
I saw this down 30% at the open and trading in the 90s. I logged into my account and put in a market buy order that took about 5 minutes to get filled, and was finally filled at around 104. I put in another market order, which never got filled, and which I then canceled when this went through 120. It seems pretty clear to me that a retail investor would have had a near impossible chance to get the cheap shares in size, even through market orders.